SK Chemical Wins `New Drug' Award.

From: Korea Times (Seoul, Korea) | Date: December 29, 1999 | Copyright information

SK Chemical won the nation's first award for developing a new drug yesterday in recognition for its next-generation medicine to treat stomach cancer.

The Korea Drug Research Association (KDRA) presented the Korea New Drug Award to the pharmaceutical arm of the SK Group for ``heptaplatin,'' a platinum complex drug which has proved highly effective in fighting cancer.

The Korea Food and Drug Administration (KFDA) approved SK's anticancer agent as the nation's f...

Related newspaper, magazine, and journal articles from HighBeam Research

SK Chemical Wins `New Drug' Award.
Korea Times (Seoul, Korea) ; SK Chemical won the nation's first award for developing a new drug yesterday in recognition for its next-generation medicine to treat stomach cancer. The Korea Drug Research Association (KDRA) presented the Korea New Drug Award to the pharmaceutical arm of the SK Group for ``heptaplatin a platinum
Vic: New drug for Parkinson s sufferers
AAP General News (Australia) ; AAP General News (Australia) 03-29-2000 Vic: New drug for Parkinson s sufferers By Lisa Walker MELBOURNE, March 29 AAP - Up to 30 per cent of Australians ...
New drug could aid `bubble babies'
Chicago Sun-Times ; WASHINGTON - The government Friday approved a new drug that could benefit an estimated 16 children born each year who now must spend their short lives inside a plastic bubble because they lack natural defenses against disease. The new drug is intended to help so-called "bubble babies" who are
Profile: New drug studies show promising results in treatment of multiple sclerosis and Crohn's disease
All Things Considered (NPR) ; ... disease Host: MICHELE NORRIS Time: 9:00-10:00 PM MICHELE NORRIS, host: From NPR News, it's ALL THINGS CONSIDERED. I'm Michele Norris. A single, new drug is showing ... marketing. The results should be ready in a couple of years. Richard Knox, NPR News, Boston.
New Drug for Age-Related Macular Degeneration.
Kiplinger's Retirement Report ; n Bright promise for new drug. A new drug for age-related macular degeneration could be on the market next year. Lucentis, from Genentech, can restore some lost vision for people with the wet form of the disease.